top of page

Hemp THC Ban Drug Testing Update: What Changed November 12 and What Employers Should Do Before December 11

13 hours ago
3 min read
Federal Hemp THC Update

For the past several years, many employers have heard the same explanation after a positive THC result: "I only used a legal hemp product." That explanation started losing its footing on November 12, 2026, when the first phase of a new federal hemp definition took effect, and a broader phase is scheduled for December 11, 2026. If your company runs a workplace drug testing program, this hemp THC ban drugtesting update is worth ten minutes of your time this week.


What happened on November 12


In November 2025, Congress rewrote the federal definition of hemp in Section 781 of Public Law 119-37, an appropriations law. The 2018 Farm Bill had defined hemp by its delta-9 THC content, which allowed products such as delta-8 gummies, THC-O vapes, and high-THCA flower to be sold widely as "hemp." The new definition was set to take effect one year after enactment, on November 12, 2026.


In September 2026, Congress passed Public Law 119-103, a continuing appropriations law that pushed most of the changes back to December 11, 2026. One piece kept its original date. As of November 12, hemp-derived intermediate and final products containing cannabinoids that the cannabis plant cannot naturally produce (THC-O is the best-known example) no longer qualify as federal hemp. Products that fall outside the hemp definition also lose hemp's exemption under the Controlled Substances Act.


What is scheduled for December 11


Unless Congress acts again, the rest of the new definition takes effect December 11, 2026. The main changes:


  • Hemp will be measured by total THC (including THCA), not delta-9 THC alone, at 0.3% on a dry-weight basis.

  • Final consumer products will be limited to 0.4 milligrams of combined THC and similar cannabinoids per container.

  • Cannabinoids that occur naturally but are made through chemical synthesis outside the plant will also be excluded.


This part is not yet final in practice. Several bills in Congress would delay, repeal, or replace these limits with a regulatory framework, and December 11 is also a federal funding deadline, so a last-minute change is possible. We will update this post if the date moves.


Hemp THC ban drug testing: why it matters for employers


A standard workplace drug test looks for THC metabolites. It does not report whether the THC came from a dispensary, a convenience-store gummy, or a product labeled "hemp." What the new law changes is the conversation after a positive result. Products that employees assumed were legal are becoming illegal under federal law on a fixed schedule, which makes it harder to treat "it was legal hemp" as a reason to overlook a confirmed THC positive in a non-protected role.


For DOT-regulated employees, nothing about the testing rules changes. The U.S. Department of Transportation's CBD notice already makes clear that use of a CBD product is not a valid medical explanation for a marijuana positive, and Medical Review Officers verify those results as positive. Safety-sensitive employees should continue to be cautious about any hemp or CBD product.


State law still matters. The federal hemp change does not override state protections for lawful cannabis use, such as New York's protections for off-duty use, and it does not change state rules on medical marijuana or what counts as evidence of impairment.


Practical steps to take now


  • Review your drug and alcohol policy definitions. Make sure "marijuana" or "THC" covers all tetrahydrocannabinols, including delta-8, THCA, and synthetic forms, regardless of how a product is marketed.

  • Remove or revise any policy language that treats "hemp-derived" products as automatically acceptable.

  • Talk with your Medical Review Officer and testing provider about how they handle a hemp explanation on non-DOT results under your policy and state law.

  • Remind DOT-covered employees in writing that CBD and hemp products can cause a positive result and are not an accepted explanation.

  • Refresh supervisor training on reasonable suspicion so decisions rest on observed, documented behavior, not product labels.

  • Calendar December 11 and confirm before then whether Congress has changed the date.


How UBS can help


Unique Background Solutions administers DOT and Non-DOT drug and alcohol programs for employers and non-profits nationwide. If you would like a second set of eyes on your drug testing policy before December 11, or help updating supervisor training, our team is glad to walk through it with you. Visit www.uniquebackground.com to get in touch.


Sources



This post is general information, not legal advice. Employers should consult their own legal counsel about how these changes apply to their policies and workforce.

Comments


bottom of page